{"disease":{"id":"metabolic-associated-fatty-liver-disease-mafld","name":"metabolic associated fatty liver disease mafld"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06884293","title":"A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":479,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT04551716","title":"Noninvasive Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese Population","phase":"","overall_status":"COMPLETED","enrollment_count":448,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06492369","title":"MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients","phase":"","overall_status":"COMPLETED","enrollment_count":382,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT06078722","title":"Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":264,"lead_sponsor_name":"Kazakh Association of Internal Medicine Specialists","has_results":false},{"nct_id":"NCT07539584","title":"Adiponectin in Patients With Metabolic Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Moscow Regional Research and Clinical Institute (MONIKI)","has_results":false},{"nct_id":"NCT07284004","title":"Fatty Liver in Long Standing Cholecystectomy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Yasmeen Ahmed Farrag Ahmed","has_results":false},{"nct_id":"NCT06798948","title":"Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Li Lab,MD","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}